{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:36:10Z","timestamp":1769110570421,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11886-019-1097-9","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T06:09:18Z","timestamp":1551334158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular Imaging of Cardiac Amyloidosis"],"prefix":"10.1007","volume":"21","author":[{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Abikhzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Giraldeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Harel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","volume":"24","author":"JJ Maleszewski","year":"2015","unstructured":"Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24:343\u201350.","journal-title":"Cardiovasc Pathol"},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.crvasa.2012.11.018","volume":"55","author":"M Fikrle","year":"2013","unstructured":"Fikrle M, Pale\u010dek T, Kuchynka P, N\u011bme\u010dek E, Bauerov\u00e1 L, Straub J, et al. Cardiac amyloidosis: a comprehensive review. Cor Vasa. 2013;55:e60\u201375.","journal-title":"Cor Vasa"},{"key":"1097_CR3","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","volume":"29","author":"G Merlini","year":"2011","unstructured":"Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol. 2011;29:1924\u201333.","journal-title":"J Clin Oncol"},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","volume":"71","author":"NL Pereira","year":"2018","unstructured":"Pereira NL, Grogan M, Dec GW. Spectrum of restrictive and infiltrative cardiomyopathies: part 1 of a 2-part series. J Am Coll Cardiol. 2018;71:1130\u201348.","journal-title":"J Am Coll Cardiol"},{"key":"1097_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","volume":"135","author":"MS Maurer","year":"2017","unstructured":"Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation. 2017;135:1357\u201377.","journal-title":"Circulation"},{"key":"1097_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","volume":"28","author":"OK Siddiqi","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018;28:10\u201321.","journal-title":"Trends Cardiovasc Med"},{"key":"1097_CR7","first-page":"438","volume":"16","author":"L Lobato","year":"2003","unstructured":"Lobato L. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M). J Nephrol. 2003;16:438\u201342.","journal-title":"J Nephrol"},{"key":"1097_CR8","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"MA Gertz","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2451\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1097_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583\u201396.","journal-title":"N Engl J Med"},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1532-5415.2011.03868.x","volume":"60","author":"K Dharmarajan","year":"2012","unstructured":"Dharmarajan K, Maurer MS. Transthyretin cardiac amyloidoses in older North Americans. J Am Geriatr Soc. 2012;60:765\u201374.","journal-title":"J Am Geriatr Soc"},{"key":"1097_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","volume":"2","author":"SF Mohammed","year":"2014","unstructured":"Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2014;2:113\u201322.","journal-title":"JACC Heart Fail"},{"key":"1097_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/07853890701842988","volume":"40","author":"M Tanskanen","year":"2008","unstructured":"Tanskanen M, Peuralinna T, Polvikoski T, Notkola I-L, Sulkava R, Hardy J, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232\u20139.","journal-title":"Ann Med"},{"key":"1097_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","volume":"7","author":"RH Falk","year":"2014","unstructured":"Falk RH, Quarta CC, Dorbala S. How to image cardiac amyloidosis. Circ Cardiovasc Imaging. 2014;7:552\u201362.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","volume":"112","author":"RH Falk","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047\u201360.","journal-title":"Circulation"},{"key":"1097_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10741-014-9466-3","volume":"20","author":"RH Falk","year":"2015","unstructured":"Falk RH, Quarta CC. Echocardiography in cardiac amyloidosis. Heart Fail Rev. 2015;20:125\u201331.","journal-title":"Heart Fail Rev"},{"key":"1097_CR16","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P, Popovi\u0107 ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98:1442\u20138.","journal-title":"Heart"},{"key":"1097_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","volume":"3","author":"IS Syed","year":"2010","unstructured":"Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010;3:155\u201364.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jcmg.2012.04.006","volume":"5","author":"F-P Mongeon","year":"2012","unstructured":"Mongeon F-P, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging. 2012;5:897\u2013907.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570\u20139.","journal-title":"Circulation"},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","volume":"9","author":"SJ Boynton","year":"2016","unstructured":"Boynton SJ, Geske JB, Dispenzieri A, Syed IS, Hanson TJ, Grogan M, et al. LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis. JACC Cardiovasc Imaging. 2016;9:680\u20136.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR21","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","volume":"2","author":"BA Austin","year":"2009","unstructured":"Austin BA, Tang WHW, Rodriguez ER, Tan C, Flamm SD, Taylor DO, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2:1369\u201377.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12410-017-9399-z","volume":"10","author":"S Pawar","year":"2017","unstructured":"Pawar S, Haq M, Ruberg FL, Miller EJ. Imaging options in cardiac amyloidosis: differentiating AL from ATTR. Curr Cardiovasc Imaging Rep. 2017;10:1.","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"1097_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/0002-8703(82)90331-3","volume":"103","author":"TA Wizenberg","year":"1982","unstructured":"Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J. 1982;103:468\u201373.","journal-title":"Am Heart J"},{"key":"1097_CR24","doi-asserted-by":"crossref","unstructured":"Vallabhajosula S, Owunwanne A. Basis of radiopharmaceutical localization. Pathophysiol Basis Nucl Med [Internet]. Springer, Cham; 2015 [cited 2018 Jun 8]. p. 45\u201368. Available from: \n                      https:\/\/link.springer.com\/chapter\/10.1007\/978-3-319-06112-2_3\n                      \n                    .","DOI":"10.1007\/978-3-319-06112-2_3"},{"key":"1097_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4:659\u201370.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR26","doi-asserted-by":"crossref","unstructured":"Rapezzi C, Gagliardi C, Milandri A. Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis. J Nucl Cardiol. 2018.","DOI":"10.1007\/s12350-018-1235-6"},{"key":"1097_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00259-001-0730-0","volume":"29","author":"M Puille","year":"2002","unstructured":"Puille M, Altland K, Linke RP, Steen-M\u00fcller MK, Kiett R, Steiner D, et al. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy. Eur J Nucl Med Mol Imaging. 2002;29:376\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1097_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","volume":"38","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2011;38:470\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1097_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jcmg.2012.02.015","volume":"5","author":"CC Quarta","year":"2012","unstructured":"Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, Ferlini A, et al. Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. JACC Cardiovasc Imaging. 2012;5:755\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR30","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"\u2022\u2022 Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404\u201312 This large multicentric study of 1217 patients proposes and validates a non-invasive algorithm for the investigation of patients with suspected cardiac amyloidosis.","journal-title":"Circulation"},{"issue":"11","key":"1097_CR31","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","volume":"45","author":"G Treglia","year":"2018","unstructured":"\u2022\u2022 Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, et al. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Eur J Nucl Med Mol Imaging. 2018;45(11):1945\u201355 This meta-analysis reviews the diagnosis accuracy of bone scintigraphy in patient with suspected ATTR cardiac amyloidosis and confirms the high sensitivity and specificity of the modality.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1097_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"Bokhari S, Casta\u00f1o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99mTc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Clinical perspective. Circ Cardiovasc Imaging. 2013;6:195\u2013201.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1097_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","volume":"22","author":"A Galat","year":"2015","unstructured":"Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, et al. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid. 2015;22:210\u201320.","journal-title":"Amyloid"},{"key":"1097_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, Cooke RMT, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46:1076\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"1097_CR35","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s12350-016-0457-8","volume":"24","author":"C Gagliardi","year":"2017","unstructured":"Gagliardi C, Tabacchi E, Bonfiglioli R, Diodato S, Nanni C, Guidalotti P, et al. Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET\/CT? J Nucl Cardiol. 2017;24:746\u20139.","journal-title":"J Nucl Cardiol"},{"key":"1097_CR36","doi-asserted-by":"crossref","unstructured":"Morgenstern R, Yeh R, Castano A, Maurer MS, Bokhari S. 18 Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2017:1\u20139.","DOI":"10.1016\/S0735-1097(17)34811-8"},{"key":"1097_CR37","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","volume":"68","author":"MG Trivieri","year":"2016","unstructured":"\u2022 Trivieri MG, Dweck MR, Abgral R, Robson PM, Karakatsanis NA, Lala A, et al. 18F-sodium fluoride PET\/MR for the assessment of cardiac amyloidosis. J Am Coll Cardiol. 2016;68:2712\u20134 A first prospective study demonstrating the feasibility of NaF imaging to detect cardiac amyloidosis and differentiate between ATTR and AL cardiac amyloidoses.","journal-title":"J Am Coll Cardiol"},{"key":"1097_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s00259-008-1037-1","volume":"36","author":"AWJM Glaudemans","year":"2009","unstructured":"Glaudemans AWJM, Slart RHJA, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BPC, et al. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging. 2009;36:702\u201314.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1097_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"\u2022\u2022 Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804.","journal-title":"N Engl J Med"},{"key":"1097_CR40","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"\u2022 Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR, Carli MFD, et al. Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41:1652\u201362 First trial demonstrating increased uptake of amyloid tracer in the heart of patients with cardiac amyloidosis.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1097_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"S-P Lee","year":"2015","unstructured":"\u2022 Lee S-P, Lee ES, Choi H, Im H-J, Koh Y, Lee M-H, et al. 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging. 2015;8:50\u20139 A small study showing that 11C-PiB can differentiate between patients with cardiac amyloidosis and controls.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR42","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","volume":"57","author":"WP Law","year":"2016","unstructured":"Law WP, Wang WYS, Moore PT, Mollee PN, Ng ACT. Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study. J Nucl Med. 2016;57:1733\u20139.","journal-title":"J Nucl Med"},{"key":"1097_CR43","doi-asserted-by":"crossref","unstructured":"Park M-A, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, Falk RH, di Carli MF, Dorbala S 18F-Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study. Circ Cardiovasc Imaging. 2015;8:e002954","DOI":"10.1161\/CIRCIMAGING.114.002954"},{"key":"1097_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcmg.2009.07.014","volume":"3","author":"I Carri\u00f3","year":"2010","unstructured":"Carri\u00f3 I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3:92\u2013100.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR45","first-page":"1040","volume":"36","author":"T Nakata","year":"1995","unstructured":"Nakata T, Shimamoto K, Yonekura S, Kobayashi N, Sugiyama T, Imai K, et al. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG. J Nucl Med. 1995;36:1040\u20132.","journal-title":"J Nucl Med"},{"key":"1097_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s002590050406","volume":"26","author":"N Delahaye","year":"1999","unstructured":"Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med. 1999;26:416\u201324.","journal-title":"Eur J Nucl Med"},{"key":"1097_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","volume":"29","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol. 1997;29:168\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"1097_CR48","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s00259-018-3963-x","volume":"45","author":"E Piekarski","year":"2018","unstructured":"\u2022\u2022 Piekarski E, Chequer R, Algalarrondo V, Eliahou L, Mahida B, Vigne J, et al. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers. Eur J Nucl Med Mol Imaging. 2018;45:1108\u201318 This study demonstrates that in carriers of TTR mutation, sympathetic denervation as demonstrated by decreased MIBG uptake occurs before amyloid accumulation can be detected by increased uptake on bone scan. They concluded that MIBG could allow early detection of cardiac involvement in TTR mutation carriers.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1097_CR49","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jcmg.2016.07.008","volume":"9","author":"V Algalarrondo","year":"2016","unstructured":"Algalarrondo V, Antonini T, Th\u00e9audin M, Chemla D, Benmalek A, Lacroix C, et al. Cardiac dysautonomia predicts long-term survival in hereditary transthyretin amyloidosis after liver transplantation. JACC Cardiovasc Imaging. 2016;9:1432\u201341.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MCA Coutinho","year":"2013","unstructured":"Coutinho MCA, Cortez-Dias N, Cantinho G, Concei\u00e7\u00e3o I, Oliveira A, Bordalo e S\u00e1 A, et al. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging. 2013;6:627\u201336.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1097_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11886-018-0976-9","volume":"20","author":"V Algalarrondo","year":"2018","unstructured":"Algalarrondo V, Piekarski E, Eliahou L, Le Guludec D, Slama MS, Rouzet F. Can nuclear imaging techniques predict patient outcome and guide medical management in hereditary transthyretin cardiac amyloidosis? Curr Cardiol Rep. 2018;20:33.","journal-title":"Curr Cardiol Rep"},{"key":"1097_CR52","doi-asserted-by":"crossref","unstructured":"Slart RHJA, Glaudemans AWJM, Hazenberg BPC, Noordzij W. Imaging cardiac innervation in amyloidosis. J Nucl Cardiol. 2017:1\u201314.","DOI":"10.1007\/s12350-017-1059-9"},{"key":"1097_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s13139-015-0338-0","volume":"49","author":"JH Lee","year":"2015","unstructured":"Lee JH, Lee GY, Kim SJ, Kim KH, Jeon E-S, Lee K-H, et al. Imaging findings and literature review of 18F-FDG PET\/CT in primary systemic AL amyloidosis. Nucl Med Mol Imaging. 2015;49:182\u201390.","journal-title":"Nucl Med Mol Imaging"},{"key":"1097_CR54","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/13506129.2012.682833","volume":"19","author":"A Mekinian","year":"2012","unstructured":"Mekinian A, Jaccard A, Soussan M, Launay D, Berthier S, Federici L, et al. 18F-FDG PET\/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid. 2012;19:94\u20138.","journal-title":"Amyloid"},{"key":"1097_CR55","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","volume":"165","author":"B Ng","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005;165:1425\u20139.","journal-title":"Arch Intern Med"},{"key":"1097_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH, Gibbs SDJ, Rowczenio D, Gilbertson JA, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7:133\u201342.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1097_CR57","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016;1:880\u20139.","journal-title":"JAMA Cardiol"},{"key":"1097_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","volume":"25","author":"MA Stats","year":"2016","unstructured":"Stats MA, Stone JR. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Cardiovasc Pathol. 2016;25:413\u20137.","journal-title":"Cardiovasc Pathol"},{"key":"1097_CR59","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/dc.10370","volume":"30","author":"MA Ansari-Lari","year":"2004","unstructured":"Ansari-Lari MA, Ali SZ. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Diagn Cytopathol. 2004;30:178\u201381.","journal-title":"Diagn Cytopathol"},{"key":"1097_CR60","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.amjcard.2014.02.030","volume":"113","author":"NM Fine","year":"2014","unstructured":"Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol. 2014;113:1723\u20137.","journal-title":"Am J Cardiol"},{"key":"1097_CR61","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCULATIONAHA.107.743427","volume":"118","author":"M Holzmann","year":"2008","unstructured":"Holzmann M, Nicko A, K\u00fchl U, Noutsias M, Poller W, Hoffmann W, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation. 2008;118:1722\u20138.","journal-title":"Circulation"},{"key":"1097_CR62","doi-asserted-by":"crossref","unstructured":"Promislow SJ, Ruddy TD. The evolving landscape of nuclear imaging in cardiac amyloidosis. J Nucl Cardiol 2018;","DOI":"10.1007\/s12350-018-1295-7"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1097-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-019-1097-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1097-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:22:38Z","timestamp":1582849358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-019-1097-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1007\/s11886-019-1097-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"28 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Matthieu Pelletier-Galarneau, Gad Abikhzer, Genevieve Giraldeau, and Francois Harel declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"12"}}